Records containing: Parkinson Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-17Effectiveness of a High-intensity Functional Training (HIFT) Program on Functional and Cognitive Performance in People with Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2025-03-14PARKINSON BRASIL - Database on Motor and Non-Motor Aspects of Parkinson's Disease in Brazil
-
CLINICAL_TRIALS study record update · 2025-03-14Longitudinal Outcomes of Deep Brain Stimulation in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-03-13An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy
-
CLINICAL_TRIALS study record update · 2025-03-13Istradefylline Effect on Parkinson's Disease Tremor, Motor Symptoms and Non-motor Symptoms
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-13Colorado Oral Strengthening Device
-
CLINICAL_TRIALS study record update · 2025-03-12The Accuracy of Digital Assessment of Performance Trial (ADAPT): Walk Test Study
-
CLINICAL_TRIALS study record update · 2025-03-12A Randomized, Parallel Group, Multicentre, Multinational, Prospective, Open-label Exploratory Study to Evaluate the add-on Effect of Opicapone 50 mg or Levodopa 100 mg as First Strategy for the Treatment of Wearing-off in Patients With Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2025-03-12Open-label, Single-arm, Pilot Study to Evaluate the Effect of Opicapone 50 mg on Parkinson's Disease Patients With End-of-dose Motor Fluctuations and Associated Sleep Disorders
-
CLINICAL_TRIALS study record update · 2025-03-12Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease and Controls
-
CLINICAL_TRIALS study record update · 2025-03-11A Prospective, Single-center, Single-arm, Exploratory, 24-Month Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Subjects With Alzheimer's Disease/ Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-03-11GEnetic Counseling Through VIRTUAL Visits in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-03-11Use of Oculometric Measures in the Differential Diagnosis of Typical and Atypical Parkinsonian Conditions: a Pilot Study
-
CLINICAL_TRIALS study record update · 2025-03-10A Phase I, Randomized Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Determine the Safety, Tolerability and Pharmacokinetics (PK) of IkT-148009 in Older Adult and Elderly Healthy Volunteers With Extension Into Parkinson's Patients
-
CLINICAL_TRIALS study record update · 2025-03-07Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments
-
CLINICAL_TRIALS study record update · 2025-03-07Effects of the HiBalance-program: Linking Clinical Signs and Symptoms to Changes in the Brain in People With Parkinson´s Disease
-
CLINICAL_TRIALS study record update · 2025-03-06Does Acrylamide Increase the Risk of Neurodegenerative and Cardiovascular Disease?
-
CLINICAL_TRIALS study record update · 2025-03-05Examining the Clinical Significance of the Change in Manual Dexterity of Parkinson's Patients Receiving Conventional Physiotherapy
-
CLINICAL_TRIALS study record update · 2025-03-05A Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of KM-819 in Healthy Older Adults and Participants with Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-03-05Determination of the Minimal Detectable Change and Minimum Clinically Important Change Score of the Parkinson's Disease Questionnaire-8
-
CLINICAL_TRIALS study record update · 2025-03-05UAB Neuroinflammation in Parkinson's Disease - TSPO-PET Substudy
-
CLINICAL_TRIALS study record update · 2025-03-04Cerebello-spinal Direct Current Stimulation Associated with Treadmill Gait Training in Functional Mobility in Patients with Parkinsons Disease
-
CLINICAL_TRIALS study record update · 2025-03-04Transcranial Direct Current Stimulation (tDCS) to Improve Cognitive Function and Cognitive Fatigue in Parkinson's Patients
-
CLINICAL_TRIALS study record update · 2025-03-04TOPAZ: Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-03-04Phase II, Double Blind, Randomized, Placebo Controlled, Parallel Group, Trial to Explore the Potential Anti-dyskinetic Properties of CPL500036 (PDE10A Inhibitor) in Patients with Parkinson's Disease Suffering from Levodopa Induced Dyskinesia